Evidence map›Paper›PMID 36984632›Full record

ArticleMedicina (Kaunas, Lithuania)2023

Programmed Death-Ligand 1-Positive Squamous Cell Carcinoma Spontaneously Regressed after Percutaneous Needle Biopsy.

Masayuki Sasahara, Hiroki Takahashi, Takashi Ohchi, Naohiro Nomura, Kentaro Kodama, Kimiyuki Ikeda, Hirotaka Nishikiori, Kenzo Okamoto, Hirofumi Chiba

Open access · goldAbstract readCase Reports
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Masayuki SasaharaDepartment of Respirology, Sokujin-kai Kitahiroshima Hospital, Kitahiroshima 061-1121, Japan.
Hiroki TakahashiDepartment of Respirology, Sokujin-kai Kitahiroshima Hospital, Kitahiroshima 061-1121, Japan.
Takashi OhchiDepartment of Respirology, Sokujin-kai Kitahiroshima Hospital, Kitahiroshima 061-1121, Japan.
Naohiro NomuraDepartment of Respirology, Sokujin-kai Kitahiroshima Hospital, Kitahiroshima 061-1121, Japan.
Kentaro KodamaDepartment of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan.
Kimiyuki IkedaDepartment of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan.
Hirotaka NishikioriDepartment of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan.ORCID 0000-0002-0573-9344
Kenzo OkamotoDepartment of Pathology, Hokkaido Chuo Rosai Hospital, Iwamizawa 068-0004, Japan.
Hirofumi ChibaDepartment of Respiratory Medicine and Allergology, Sapporo Medical University School of Medicine, Sapporo 060-8556, Japan.
Sapporo Medical University · JPChubu Rosai Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spontaneous lung cancer regression is a very rare course of disease. A 60-year-old male patient was admitted to our hospital with pneumonia and a 19 mm-sized nodule shadow in the S4 of the left lung on chest computed tomography (CT). A percutaneous needle biopsy was performed, and a diagnosis of programmed death-ligand 1-positive squamous cell lung carcinoma was made based on pathological findings. The patient was followed up with imaging because the lesion has reduced in size on chest CT. We report the possibility that cellular immune mechanisms triggered by needle biopsy contributed to spontaneous regression.

Indexed as

Carcinoma, Non-Small-Cell LungCarcinoma, Squamous CellLung NeoplasmsB7-H1 AntigenBiopsy, NeedleHumansLungMaleMiddle AgedB7-H1 AntigenCD274 protein, humanlung cancerpercutaneous needle biopsypneumoniaprogrammed death-ligand 1spontaneous regression

Identifiers

PMID36984632
PMCPMC10055785
OpenAlexW4353062198

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.